Morikawa, K., Nakamura, A., Shimazaki, T., & Sakamoto, N. (2018). Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: Current evidence. Drug Des Devel Ther.
Citação norma ChicagoMorikawa, Kenichi, Akihisa Nakamura, Tomoe Shimazaki, and Naoya Sakamoto. "Safety and Efficacy of Elbasvir/grazoprevir for the Treatment of Chronic Hepatitis C: Current Evidence." Drug Des Devel Ther 2018.
Citação norma MLAMorikawa, Kenichi, Akihisa Nakamura, Tomoe Shimazaki, and Naoya Sakamoto. "Safety and Efficacy of Elbasvir/grazoprevir for the Treatment of Chronic Hepatitis C: Current Evidence." Drug Des Devel Ther 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.